Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Sunrun stock drops today as Treasury yields tick higher in year-end trading

Sunrun stock drops today as Treasury yields tick higher in year-end trading

NEW YORK, December 31, 2025, 15:30 ET — Regular session Sunrun Inc. shares fell 3.8% to $18.37 in afternoon trading on Wednesday, extending a pullback in rate-sensitive solar names on the final session of the year. The Nasdaq-listed stock opened at $19.06 and traded between $18.34 and $19.20. The move matters now because residential solar installers are closely tied to interest rates: higher borrowing costs can raise customer monthly payments and pressure the economics of financing-heavy business models. U.S. Treasury yields edged higher after a surprise drop in jobless claims, with the 10-year yield up about 1 basis point —
BillionToOne (BLLN) stock slides 4% in thin year-end trade as investors look to January catalysts

BillionToOne (BLLN) stock slides 4% in thin year-end trade as investors look to January catalysts

NEW YORK, December 31, 2025, 15:27 ET — Regular session. Shares of BillionToOne (BLLN.O) fell about 4% on Wednesday, sliding $3.49 to $81.61 in afternoon trading. The stock has traded between $81.25 and $89.36, with about 243,000 shares changing hands. The move came on the final trading day of 2025, when liquidity is typically thin and price swings can look bigger than the underlying news. “It’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity, pointing to profit-taking when liquidity is low. U.S. markets are closed on Thursday for New
Rigetti stock price today: RGTI dips in year-end session as tech pullback pressures quantum names

Rigetti stock price today: RGTI dips in year-end session as tech pullback pressures quantum names

NEW YORK, December 31, 2025, 15:21 ET — Regular session. Rigetti Computing Inc (RGTI) shares were down 1.7% at $22.03 by 3:21 p.m. ET on Wednesday, 38 cents below their prior close. The stock traded between $21.96 and $22.65, with about 16.9 million shares changing hands. The move came as Wall Street’s major indexes edged lower in thin year-end trading, keeping pressure on smaller, high-volatility names. “it’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity. Reuters That matters for Rigetti because late-year liquidity can dry up fast, amplifying intraday
Why Super Micro (SMCI) stock is down today: an exec retirement filing meets year-end AI trade

Why Super Micro (SMCI) stock is down today: an exec retirement filing meets year-end AI trade

NEW YORK, December 31, 2025, 15:16 ET — Regular session Super Micro Computer, Inc. shares fell 1.7% to $29.15 in afternoon trading on Wednesday, after a regulatory filing showed the AI server maker’s head of operations will retire at year-end. The stock traded between $29.12 and $29.86. The timing matters because Super Micro’s customers care less about buzzwords and more about delivery schedules, power draw and cooling. Any hint of execution risk can move the stock quickly, especially into year-end when liquidity thins and position-squaring can exaggerate swings. The company said Senior Vice President of Operations George Kao will retire
Alignment Healthcare stock rises today despite new insider-sale filings, with ALHC near $20

Alignment Healthcare stock rises today despite new insider-sale filings, with ALHC near $20

NEW YORK, December 31, 2025, 14:50 ET — Regular session Alignment Healthcare, Inc. shares rose about 3.4% to $19.90 in mid-afternoon trading on Wednesday, after earlier touching $19.93 as the stock fluctuated between $18.83 and $19.93. The move came as investors weighed a cluster of insider-transaction disclosures that can shape sentiment in smaller healthcare names, especially in thin year-end markets. Liquidity has been patchy heading into the New Year holiday, a setup that can magnify price swings. “Profit-taking opportunities” tend to show up “when liquidity was low,” said Giuseppe Sette, co-founder and president of Reflexivity. Reuters A Form 4 filing
Cytokinetics stock jumps today as CYTK traders focus on Myqorzo launch and insider filing

Cytokinetics stock jumps today as CYTK traders focus on Myqorzo launch and insider filing

NEW YORK, December 31, 2025, 14:52 ET — Regular session Cytokinetics, Incorporated shares rose 3.7% to $63.63 in afternoon trading on Wednesday, after touching $64.40 earlier in the session. The stock traded as low as $60.87, while the S&P 500 tracker and Nasdaq 100 fund were both down about 0.4% to 0.5%. The move matters because Cytokinetics is nearing its first U.S. commercial launch after winning FDA approval for Myqorzo (aficamten) this month. The company has said the drug should be available in the U.S. in the second half of January and will be distributed under a REMS program —
F&G stock drops nearly 3% as Fidelity National’s share distribution hits on Dec. 31

F&G stock drops nearly 3% as Fidelity National’s share distribution hits on Dec. 31

NEW YORK, December 31, 2025, 14:56 ET — Regular session Shares of F&G Annuities & Life Inc (FG) fell 2.9% to $30.90 in afternoon trading on Wednesday, after touching a session low of $30.90. The stock traded as high as $32.09 earlier in the day. The move puts a spotlight on an unusual year-end catalyst: new supply of FG shares entering the market via a distribution by its majority owner, Fidelity National Financial (FNF). That matters now because distributions like this can reshape short-term trading. They often bring in shareholders who didn’t choose the stock and may sell quickly, increasing
Freedom Holding stock today: FRHC slides 3% in year-end session as markets drift lower

Freedom Holding stock today: FRHC slides 3% in year-end session as markets drift lower

NEW YORK, December 31, 2025, 14:07 ET — Regular session Freedom Holding Corp (FRHC) shares fell about 3% on Wednesday, sliding to $121.99 in afternoon trading after touching an intraday low of $121.64. The drop lands on Wall Street’s final session of 2025, when trading often thins out as investors close books and rebalance portfolios. In a low-liquidity market — meaning fewer buyers and sellers to absorb trades — smaller orders can move prices more than usual. U.S. stocks drifted lower in holiday-thin trading, with tech weighing on the major indexes. “It’s perfectly fine in any bull market to have
Trump offshore wind freeze heads to court as judge seeks classified evidence in Dominion case

Trump offshore wind freeze heads to court as judge seeks classified evidence in Dominion case

NEW YORK, December 31, 2025, 14:45 ET A U.S. federal judge in Virginia has delayed Dominion Energy’s bid to quickly restart offshore construction on its Coastal Virginia Offshore Wind project, as the court seeks access to classified material the Trump administration says underpins its stop-work order. The next hearing is set for Jan. 16, after the judge directed the government to submit the classified information to the court by Jan. 9 and to say by Dec. 31 whether it would share that material with Dominion’s security-cleared lawyers. Maritime Executive The case has become an early legal test of President Donald
India fires two Pralay missiles back-to-back in salvo test, signalling induction is near

India fires two Pralay missiles back-to-back in salvo test, signalling induction is near

NEW YORK, December 31, 2025, 14:29 ET India’s Defence Research and Development Organisation (DRDO) on Wednesday test-fired two indigenously developed Pralay missiles in quick succession off the coast of Odisha, in a user evaluation trial that officials said underscored the system’s readiness for service. The test matters because user evaluation trials are a late-stage proving process, typically involving the military “users” who will operate the system, and are usually among the final steps before formal induction. It also comes as India continues to strengthen its domestic weapons programme and expand conventional strike options, against the backdrop of long-running rivalry with
31 December 2025
CoreWeave stock drops as insider sale filing hits thin year-end trade — what’s next for CRWV

CoreWeave stock drops as insider sale filing hits thin year-end trade — what’s next for CRWV

NEW YORK, December 31, 2025, 14:40 ET — Regular session CoreWeave Inc shares were down 3.1% at $71.63 on Wednesday afternoon, after an insider sale disclosure drew attention in thin year-end trading. The stock hit a session low of $71.46. The timing matters because trading conditions are patchy heading into the New Year’s Day holiday, when lower liquidity can amplify moves in single names. For a recently listed company with a volatile tape, incremental supply can weigh on sentiment even without new fundamental news. Investors have also been sensitive to funding and dilution risk in capital-intensive AI infrastructure plays. CoreWeave
UHS stock sinks today after CEO contract extension filing — here’s what moved the shares

UHS stock sinks today after CEO contract extension filing — here’s what moved the shares

NEW YORK, December 31, 2025, 13:23 ET — Regular session Universal Health Services, Inc. shares were down 2.75% at $218.87 in afternoon trading on Wednesday, extending losses as the hospital operator underperformed its peer group. The stock was down $6.19 from Tuesday’s close and touched $218.59 at the session low, with about 293,000 shares traded. The move matters now because governance and pay disclosures can become a catalyst in thin year-end trading, when investors reassess leadership incentives and stewardship. Hospital operators also enter 2026 facing close scrutiny on costs, staffing and reimbursement — areas where execution can swing margins quickly.
1 462 463 464 465 466 885

Stock Market Today

Lloyds share price steadies after buyback update and BoE rate jitters — what to watch next week

Lloyds share price steadies after buyback update and BoE rate jitters — what to watch next week

7 February 2026
LONDON, February 7, 2026, 08:48 GMT — Market closed Lloyds Banking Group shares finished Friday higher after the lender flagged another round of share buybacks, helping to steady the stock at the end of a volatile two-day swing driven by shifting expectations for UK interest rates. With London markets closed for the weekend, the focus moves to Monday’s open and whether rate-cut pricing keeps easing pressure on bank earnings. Lloyds is a UK-focused lender, and investors tend to treat it as a clean play on domestic growth, mortgages and the direction of Bank Rate. That makes the stock quick to
Vodafone shares steady up after Q3 wobble — Germany, buyback and next results now set the tone

Vodafone shares steady up after Q3 wobble — Germany, buyback and next results now set the tone

7 February 2026
Vodafone shares rose 1.47% to 110.60p Friday, recovering part of Thursday’s 4.68% drop after a Q3 update. Group revenue climbed 6.5% to €10.5 billion, but Germany’s 0.7% service revenue growth missed some forecasts. Vodafone launched a new €500 million buyback tranche, bringing total buybacks since May to €3.5 billion. Investors remain focused on Germany’s pace and cash flow execution.
NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

7 February 2026
NatWest shares closed up 1.45% at 659.4 pence Friday, buoyed by a buyback of 797,428 shares and a new digital mortgage deal with Rightmove. The Bank of England held rates at 3.75% but signaled possible cuts, with markets pricing in two reductions for 2026. NatWest plans to expand its Accelerator community to 50,000 members by 2026. Annual results are due Feb. 13.
Unilever share price holds at 5,250p as results week looms — what investors watch next

Unilever share price holds at 5,250p as results week looms — what investors watch next

7 February 2026
Unilever shares closed flat at 5,250p in London Friday, underperforming the FTSE 100’s 0.6% gain. The company issued 4.2 million new shares for employee plans, bringing total shares to over 2.18 billion. Investors await Q4 and full-year results on Feb. 12, with analyst consensus pointing to 3.9% Q4 sales growth. Unilever’s U.S. ADR rose 0.8% to $72.12.
Go toTop